Related Experiment Video

Updated: Dec 3, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.5K

Author Correction: Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson-Gilford

Madaiah Puttaraju1, Michaela Jackson2, Stephanie Klein2

  • 1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Nature Medicine
|June 2, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.2K
TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
09:18

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

6.0K

Related Experiment Videos

Last Updated: Dec 3, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.5K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.2K
TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
09:18

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

6.0K

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.3K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.3K
Alternative RNA Splicing02:18

Alternative RNA Splicing

22.9K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
22.9K

Articles linked to this work by shared authors, journal, and citation graph.

Cytoplasmic DNA Sensing Links LINE-1 Expression to Neuronal Senescence in Alzheimer's Disease.

bioRxiv : the preprint server for biology·2026

Individualized antisense oligonucleotides for SCN2A-related developmental epileptic encephalopathy.

Nature medicine·2026

Re-establishment of TAD boundary organization during DNA replication.

bioRxiv : the preprint server for biology·2026

Genome reorganization and its functional impact during breast cancer progression.

eLife·2026

Naked antisense oligonucleotides remain endolysosomally sequestered despite induced membrane damage.

bioRxiv : the preprint server for biology·2026

Enhanced splicing modulation by NMA-modified antisense oligonucleotides.

Nucleic acids research·2026

Sex-specific biological aging clocks across organs and omics.

Nature medicine·2026

Factor IX Padua AAV gene therapy in adolescents with hemophilia B: a phase 1 trial.

Nature medicine·2026

EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse.

Nature medicine·2026

Liquid biopsy for early detection of pancreatic ductal adenocarcinoma.

Nature medicine·2026

Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial.

Nature medicine·2026

Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial.

Nature medicine·2026

[Hybrid medicine in the 21st century (Part 1)].

Revue medicale suisse·2026

Peptide-Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives.

ChemMedChem·2026

Operationalizing Alzheimer's disease trials in the era of targeted therapies.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Quercetin-Based Nanotherapeutics for Targeted Drug Delivery in Alzheimer's Disease: Comparative Insights into Molecular Mechanisms, Blood-Brain Barrier Targeting and Therapeutic Perspectives.

Molecular neurobiology·2026

Mutational constraints on RSV F and its neutralization by antibodies.

Nature·2026

Identifying General Practitioners, Nurses, and Pharmacists Training Needs in Precision Medicine: A Survey Study.

The Journal of continuing education in the health professions·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us